Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Gilmar Hanck-Silva"'
Autor:
Gilmar Hanck-Silva, Edson Minatti
Publikováno v:
Brazilian Journal of Pharmaceutical Sciences, Vol 58 (2022)
Abstract In this work, polystyrene-b-poly (acrylic acid) (PS-b-PAA) nanovesicles were coated by modified chitosans aiming at studying its physicochemical parameters. The chitosan (CS) was chemically modified to add hydrophilic and/or hydrophobic grou
Externí odkaz:
https://doaj.org/article/c433c7a3a9bd4c17819982ec64cd0d08
Autor:
Gilmar Hanck-Silva, Christian Rafael Quijia, Regina Célia Galvão Frem, Renata Carolina Alves, Marlus Chorilli, Guilherme Arroyos
Publikováno v:
Critical Reviews in Microbiology. 48:161-196
Infectious diseases are one of the leading cause of mortality and morbidity worldwide. Metal-Organic Frameworks (MOFs), which are porous coordination materials composed of bridging organic ligands and metallic ions or clusters, exhibits great potenti
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::674016f073a6bf5c6bd6e24575475039
https://doi.org/10.1080/1040841x.2021.1950120
https://doi.org/10.1080/1040841x.2021.1950120
Autor:
Felipe Tita de Lima, Maria Palmira Daflon Gremião, Marlus Chorilli, Leonardo Delello Di Filippo, Gilmar Hanck-Silva, Karen Cristina dos Santos
Publikováno v:
Critical reviews in analytical chemistry. 51(5)
Bevacizumab is a chimeric monoclonal human-murine antibody originated from murine monoclonal antibody (muMAb A4.6.1) with the human immunoglobulin IgG1. BVZ binds the extracellular portion of vascular endothelial growth factor receptors (VEGFR), whic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3dbf2e0ff7c4231557ae6376a8736b44
https://pubmed.ncbi.nlm.nih.gov/32295395
https://pubmed.ncbi.nlm.nih.gov/32295395
Autor:
Gilmar Hanck-Silva, Josimar O. Eloy, Felipe Tita de Lima, Mariza Aires Fernandes, João Augusto Oshiro Junior, Marlus Chorilli, Franciele Garcia Baveloni
Publikováno v:
Critical reviews in analytical chemistry. 51(5)
Transferrin is a protein involved in iron uptake by cells and has been identified as a potential target for directing drug-loaded nanoparticles for cancer treatment and diagnosis. Most methods for conjugation of transferrin and nanoparticles involve
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4150e33d3be357ef2d341fffbcc2d14a
https://pubmed.ncbi.nlm.nih.gov/32212927
https://pubmed.ncbi.nlm.nih.gov/32212927